Welcome to Duke: New CBB PhD Cohort
This fall, the Duke Department of Biostatistics & Bioinformatics welcomed a new cohort of PhD students in Computational Biology and Bioinformatics. Hailing from across the globe, these scholars bring impressive academic backgrounds, a passion for translational research, and a wide range of personal interests, from anime and marathons to K-pop and cooking.
Welcome Biostatistics PhD Students
This fall, the Department of Biostatistics and Bioinformatics welcomed a new cohort of PhD students in biostatistics. This accomplished group brings a wide range of academic backgrounds, research interests, and personal passions to the department. Their dedication to advancing health through data science and their enthusiasm for collaborative, interdisciplinary work will enrich the Duke community.
A New Duke Discovery Could Help Target the Cells That Drive Aging and Disease
Researchers at Duke University School of Medicine have developed a powerful new tool that can detect cells that play a significant role in aging, known as senescent cells, with remarkable accuracy across a wide range of tissues and technologies.
Michael Pencina Steps Down, Joins UnitedHealth
Michael Pencina, PhD, stepped down as vice dean for data science at Duke University School of Medicine and chief data scientist for Duke Health, effective September 30, 2025. He accepted an exciting new opportunity as chief AI scientist with UnitedHealth Group
Duke Urologist and MMCi Graduate Uses Data to Streamline Patient Care
A data-driven shift at Duke Urology slashed wait times for men’s health appointment by focusing on the toughest prostate cancer and infertility cases first.
Can AI Reduce Overdiagnosis of Thyroid Cancer?
Thyroid cancer is common, but many cases — up to 77% — are believed to be over diagnosed.
Why Do Vaccines Wear Off?
Duke University School of Medicine researchers have proposed a new statistical approach to improve how scientists and policy makers use health record data to guide decisions, such as when it's time for a booster shot.
‘Evaluation cannot be afterward’: Duke Health develops framework to evaluate AI use in care
Although it aims to use AI to advance health care, two Duke Health researchers see it as a tool that requires careful evaluation and thoughtful oversight.
New AI Method Excels at Predicting Disease Risk from Clinical Notes
Matthew Engelhard, PhD, and PhD student Fengnan Li have developed a new natural language processing method that takes on the challenge of finding important details scattered throughout long documents.
With $15 Million Grant, Duke Team Expands AI Tool to Predict Teen Mental Illness
The project, co-led by Matthew Engelhard, PhD, assistant professor of biostatistics and bioinformatics, aims to bring early mental health screening to clinics where access to care is limited.